Amanda joined The Verden Group of companies in 2017 in the roles of PCMH Specialistfocused on the Florida Chapter of the American Academy of Pediatrics statewide PCMH project, and as Senior Consultant with Patient Centered Solutions.
With a background in health administration, and recent work in population health management at Phytel/IBM Watson Health, Amanda’s combined work experience brings a wealth of knowledge and expertise to our PCMH clients. Amanda’s education in healthcare began with a Bachelor’s in Health Administration from Saint Petersburg College in 2011, and a Masters of Public Health from the University of West Florida in May of 2016. In addition to her degrees, Amanda was the Office Manager in a Pediatrics practice in Crystal River Florida, where she participated in the Blue Cross Blue Shield Florida pilot PCMH program and obtained NCQA recognition for the practice.
Dedicated to expanding her knowledge of PCMH and helping clients navigate the path to NCQA recognition, Amanda has been coached by BCBF on PCMH concepts and has complete NCQA sponsored training seminars in 2011 and 2014, with plans to complete the NCQA training again in 2017.
Amanda is based in St. Petersburg, Florida, where she enjoys spending time outside and boating with her husband and 1-year old daughter.
Outsourcing chronic care management can have many benefits for small practices. Here are tips on how to successfully implement a CCM program that would be advantageous for both your practice and patients.
"Successfully implementing a CCM program starts with laying the operational groundwork: integrating new staff and installing healthIT software. Committing time and resources into integrating remote care managers early on is critical to reaping the benefits long term. By treating remote care coordinators as true extensions of your staff, adapting to the culture, tone, and workflow of your practice, they eventually become integral parts of practice operations, and in some cases, may even be willing to work in the office a few days a week to get additional face-to-face time with practice staff and patients. This frees up existing staff to manage other important tasks."
Pfizer reports positive results for COVID-19 vaccine in children. Read the latest here.
"Pfizer and COVID-19 vaccine development partner BioNTech reported Monday positive topline results from a pivotal trial of the vaccine in children aged 5 to 11 years. The vaccine was determined to be safe and well tolerated in the youngest age group yet to receive the 2-shot series, according to a Pfizer press statement.
Results of the phase 2/3 trial showed a robust neutralizing antibody response to the 2-dose regimen of 10 µg administered 21 days apart—a dose smaller than the 30-µg given to people aged ≥12 years. The antibody responses among the younger volunteers were comparable to that seen in trials of the vaccine in those aged 16 to 25 years, according to the company. Side effects, too, were comparable to those seen in the older cohort."
The AAP has new recommendations for using consistent terminology to describe and classify unexpected and unexplained infant deaths.
"Throughout the years, many new terms have been used to classify infant deaths to reflect whether they are believed to be accidental or undetermined or fall under other categories," said Dr. Vincent J. Palusci, MD, MS, FAAP, a co-author of the report.
"This has led to inconsistencies in terms used, which in turn increases the chances of communication errors and misunderstandings. Our goal is to establish uniform and shared terminology so that we can best support families after their loss and work to prevent more deaths."